Cells-to-sequence sample preparation for next-generation sequencing

用于下一代测序的细胞到测序样品制备

基本信息

  • 批准号:
    8980733
  • 负责人:
  • 金额:
    $ 56.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-24 至 2017-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Sample preparation for next-generation sequencing (NGS) is an inefficient, complex, multistep process that is difficult to automate. Sequencing library construction consists of around a dozen biochemical operations. Currently, automation of these steps requires highly customized automation equipment and highly trained technicians to manage the workflow. There are only a couple of automation products that address this problem, but these only perform part of the overall library construction process-they do not perform DNA purification from the biological sample. As NGS technology begins to move into the diagnostic world, there is an urgent need for walkaway, closed automated systems that dramatically simplify the NGS sample prep process. In addition, pioneering NGS companies and researchers are pushing the sequencing field toward very long-read, single-molecule sequencing technologies. This move to longer-read sequencing methods poses new challenges for NGS sample prep. Most popular DNA extraction methods do not produce long genomic DNA molecules, and many "third-gen" sequencing companies are actively seeking new, reliable methods for extracting large, intact DNA molecules, and converting them into sequencing libraries. In the course of developing new DNA size-selection technologies for NGS, we have conceived of a powerful technology for automated, rapid, purification of very long genomic DNA. In addition, the technology can be easily adapted to also produce NGS libraries for both traditional short-read and third-gen long-read sequencing platforms. By combining these two capabilities, our phase II application seeks to produce a system capable of producing finished NGS libraries from crude blood samples, in a single completely automated workflow. Such a system will dramatically reduce the cost and complexity of NGS sample prep, and speed the application of NGS to diagnostics.


项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TRUETT C BOLES其他文献

TRUETT C BOLES的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TRUETT C BOLES', 18)}}的其他基金

High-throughput size-selection system for long-read sequencing library preparation
用于长读长测序文库制备的高通量尺寸选择系统
  • 批准号:
    10480521
  • 财政年份:
    2022
  • 资助金额:
    $ 56.28万
  • 项目类别:
Targeted long-read sequencing sample preparation using Cas9 nucleases
使用 Cas9 核酸酶进行靶向长读长测序样品制备
  • 批准号:
    9980971
  • 财政年份:
    2018
  • 资助金额:
    $ 56.28万
  • 项目类别:
Integrated system for preparation of NGS libraries from crude biological samples
用于从粗生物样品制备 NGS 文库的集成系统
  • 批准号:
    8314280
  • 财政年份:
    2012
  • 资助金额:
    $ 56.28万
  • 项目类别:
ARC DETECTION FOR AMPLIFICATION BASED GENETIC TYPING
用于基于扩增的基因分型的电弧检测
  • 批准号:
    2030097
  • 财政年份:
    1997
  • 资助金额:
    $ 56.28万
  • 项目类别:
TOPOLOGICAL STUDIES ON SITE-SPECIFIC DNA RECOMBINATION
位点特异性 DNA 重组的拓扑研究
  • 批准号:
    3041477
  • 财政年份:
    1988
  • 资助金额:
    $ 56.28万
  • 项目类别:
TOPOLOGICAL STUDIES ON SITE-SPECIFIC DNA RECOMBINATION
位点特异性 DNA 重组的拓扑研究
  • 批准号:
    3041475
  • 财政年份:
    1987
  • 资助金额:
    $ 56.28万
  • 项目类别:
TOPOLOGICAL STUDIES ON SITE-SPECIFIC DNA RECOMBINATION
位点特异性 DNA 重组的拓扑研究
  • 批准号:
    3041476
  • 财政年份:
    1987
  • 资助金额:
    $ 56.28万
  • 项目类别:

相似海外基金

ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
  • 批准号:
    10935820
  • 财政年份:
    2023
  • 资助金额:
    $ 56.28万
  • 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
  • 批准号:
    10932514
  • 财政年份:
    2023
  • 资助金额:
    $ 56.28万
  • 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
  • 批准号:
    10704845
  • 财政年份:
    2023
  • 资助金额:
    $ 56.28万
  • 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
  • 批准号:
    10709085
  • 财政年份:
    2023
  • 资助金额:
    $ 56.28万
  • 项目类别:
Advanced Development of Gemini-DHAP
Gemini-DHAP的高级开发
  • 批准号:
    10760050
  • 财政年份:
    2023
  • 资助金额:
    $ 56.28万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10409385
  • 财政年份:
    2022
  • 资助金额:
    $ 56.28万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10710595
  • 财政年份:
    2022
  • 资助金额:
    $ 56.28万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10630975
  • 财政年份:
    2022
  • 资助金额:
    $ 56.28万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
  • 批准号:
    10710588
  • 财政年份:
    2022
  • 资助金额:
    $ 56.28万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10788051
  • 财政年份:
    2022
  • 资助金额:
    $ 56.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了